Related references
Note: Only part of the references are listed.Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Delta(9)-Tetrahydrocannabinol
Douglas L. Boggs et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Procarbazine, lomustine and vincristine toxicity in low-grade gliomas
G. Jutras et al.
CURRENT ONCOLOGY (2018)
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
LONG-TERM FOLLOW-UP RESULTS OF CONCOMITANT CHEMORADIOTHERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE THERAPY FOR GLIOBLASTOMA MULTIFORME PATIENTS. THE IMPORTANCE OF MRI INFORMATION IN SURVIVAL: SINGLE-CENTER EXPERIENCE
Lukacs Gabor et al.
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
Israel Lopez-Valero et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CNS DRUGS (2018)
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
Coral Gonzalez-Garcia et al.
EXPERIMENTAL NEUROLOGY (2017)
Neurological Aspects of Medical Use of Cannabidiol
Carmen Mannucci et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
Saphala Dhital et al.
CELLULAR IMMUNOLOGY (2017)
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Sonia Hernandez-Tiedra et al.
AUTOPHAGY (2016)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The use of cannabinoids as anticancer agents
Guillermo Velasco et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
Sean D. McAllister et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Guy A. Cabral et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
Katherine A. Scott et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Cannabidiol as potential anticancer drug
Paola Massi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
Marta Solinas et al.
PLOS ONE (2013)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L. C. Hygino da Cruz et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Sofia Torres et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
Jennifer L. Clarke et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
Maria Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis
Neil G. Burnet et al.
RADIOTHERAPY AND ONCOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
A pilot clinical study of Δ9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M. Guzman et al.
BRITISH JOURNAL OF CANCER (2006)
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
A Carracedo et al.
CANCER CELL (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidemiology and etiology of gliomas
H Ohgaki et al.
ACTA NEUROPATHOLOGICA (2005)
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities
JC Buckner et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemotherapy for high-grade gliomas
E Galanis et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
